These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30742270)

  • 1. Gene Editing in 3D Cultured Nephron Progenitor Cell Lines.
    Li Z; Araoka T; Belmonte JCI
    Methods Mol Biol; 2019; 1926():151-159. PubMed ID: 30742270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D Culture Supports Long-Term Expansion of Mouse and Human Nephrogenic Progenitors.
    Li Z; Araoka T; Wu J; Liao HK; Li M; Lazo M; Zhou B; Sui Y; Wu MZ; Tamura I; Xia Y; Beyret E; Matsusaka T; Pastan I; Rodriguez Esteban C; Guillen I; Guillen P; Campistol JM; Izpisua Belmonte JC
    Cell Stem Cell; 2016 Oct; 19(4):516-529. PubMed ID: 27570066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo regeneration of interspecies chimeric kidneys using a nephron progenitor cell replacement system.
    Fujimoto T; Yamanaka S; Tajiri S; Takamura T; Saito Y; Matsumoto K; Takase K; Fukunaga S; Okano HJ; Yokoo T
    Sci Rep; 2019 May; 9(1):6965. PubMed ID: 31061458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term expandable mouse and human-induced nephron progenitor cells enable kidney organoid maturation and modeling of plasticity and disease.
    Huang B; Zeng Z; Kim S; Fausto CC; Koppitch K; Li H; Li Z; Chen X; Guo J; Zhang CC; Ma T; Medina P; Schreiber ME; Xia MW; Vonk AC; Xiang T; Patel T; Li Y; Parvez RK; Der B; Chen JH; Liu Z; Thornton ME; Grubbs BH; Diao Y; Dou Y; Gnedeva K; Ying Q; Pastor-Soler NM; Fei T; Hallows KR; Lindström NO; McMahon AP; Li Z
    Cell Stem Cell; 2024 Jun; 31(6):921-939.e17. PubMed ID: 38692273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of Mouse Nephron Progenitor Cells in Aggregates with Gamma-Secretase Inhibitor.
    Yuri S; Nishikawa M; Yanagawa N; Jo OD; Yanagawa N
    PLoS One; 2015; 10(6):e0129242. PubMed ID: 26075891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
    Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
    Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activin Is Superior to BMP7 for Efficient Maintenance of Human iPSC-Derived Nephron Progenitors.
    Tanigawa S; Naganuma H; Kaku Y; Era T; Sakuma T; Yamamoto T; Taguchi A; Nishinakamura R
    Stem Cell Reports; 2019 Aug; 13(2):322-337. PubMed ID: 31378669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
    Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
    Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off- and on-target effects of genome editing in mouse embryos.
    Ayabe S; Nakashima K; Yoshiki A
    J Reprod Dev; 2019 Feb; 65(1):1-5. PubMed ID: 30518723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Human Renal Vesicles in Mouse Organ Niche Using Nephron Progenitor Cell Replacement System.
    Fujimoto T; Yamanaka S; Tajiri S; Takamura T; Saito Y; Matsumoto N; Matsumoto K; Tachibana T; Okano HJ; Yokoo T
    Cell Rep; 2020 Sep; 32(11):108130. PubMed ID: 32937125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cas9 immunity creates challenges for CRISPR gene editing therapies.
    Crudele JM; Chamberlain JS
    Nat Commun; 2018 Aug; 9(1):3497. PubMed ID: 30158648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
    Ahmad G; Amiji M
    Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust genome editing of CRISPR-Cas9 at NAG PAMs in rice.
    Meng X; Hu X; Liu Q; Song X; Gao C; Li J; Wang K
    Sci China Life Sci; 2018 Jan; 61(1):122-125. PubMed ID: 29285711
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephron progenitor cell commitment: Striking the right balance.
    O'Brien LL
    Semin Cell Dev Biol; 2019 Jul; 91():94-103. PubMed ID: 30030141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.